Speakers

Keynote Speakers
All Speakers

Aaraj
Elie
MENAHRA
Abagiu
Adrian
National Institute for Infectious Diseases
Romania
Abel-Ollo
Katri
Estonian National Institute for Health Development (NIHD)
Estonia
Abeysekera
Kushala
University of Bristol
United Kingdom
Abramovici
Hanan
Health Canada
Canada
Adenibuyan
Peter
Federal Neuro Psychiatric Hospital Yaba, Lagos
Nigeria
Ades
Julie-Emilie
OFDT
France
Aguiar
Filomena
Fundação Portuguesa A Comunidade Contra a SIDA
Portugal
Akhurst
Jane
University of Tasmania
Tasmania
Alarie-Vézina
Pascale
Université du Québec à Trois-Rivières
Canada
Albertella
Lucy
Monash University
Australia
Aldridge
Judith
University of Manchester
United Kingdom
Andersen
Kjeld
Professor in Psychiatry
Syddansk Universitet
Denmark
Andreu
Magalí
University of Barcelona
Spain
António
Patrícia
Unidade de Alcoologia de Lisboa
Portugal
Anzenberger
Judith
Austrian Focal Point for Drugs and Drug Addiction
Austria
Araújo
Ana
Institute for Evidence Based Health, Faculty of Medicine, University of Lisbon
Portugal
Arnevik
Espen Ajo
Oslo University Hospital
Norway
Arpa
Sharon
Acting Manager - Research Team
Foundation for Social Welfare Services
Malta
Aubin
Henri-Jean
Professor of Psychiatry and Addiction Medicine
Paris-Sud University
France
Aubut
Valérie
Université du Québec à Trois-Rivières
Canada
Augusto
João
VillaRamadas International Treatment Centre
Portugal
Auwärter
Volker
Head of Forensic Toxicology Department
Freiburg University
Germany
Azbel
Lyuba
Faculty of Public Health and Policy, LSHTM
United Kingdom
Babor
Thomas
University of Connecticut School of Medicine
United States
Bailey
Genie
Associate Clinical Professor
Psychiatry at Brown University
United States
Bakkeng
Camilla Lynne
Head of Advisory
Akan advisory centre
Norway
Balcells
Maria de las Mercedes
University of Barcelona
Barcelona
Spain
Ballotta
Danilo
EMCDDA
Baptista Leite
Ricardo
Member of Parliament
Portugal
Barbosa
Fernando
School of Health, Polytechnic Institute of Porto
Portugal
Barnett
Anthony
Monash University
Australia
Barrett
Damon
Lecturer - Department of Public Health and Community Medicine
University of Gothenburg
Sweden
Barrio
Gregorio
National School of Public Health, Carlos III Health Institute
Madrid
Spain
Barrio
Pablo
Barroso
Teresa
Nursing School Coimbra
Portugal
Barroso Dias
Jorge
Portuguese Society of Occupational Medicine (SPMT)
Portugal
Bauld
Linda
University of Edinburgh
United Kingdom
Baumgartner
Christian
Swiss Research Institute for Public Health and Addiction
Switzerland
Bayrak
Belgin
Ministry of Heath
Turkey
Beauregard
Jennifer
Université de Sherbrooke
Canada
Beccaria
Franca
Head of research
Eclectica - Institute for Research and Training
Italy
Bech
Anne Berit
National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust
Norway
Becker
Gabi
Integrative Drogenhilfe
Germany
Behrendt
Silke
Belackova
Vendula
Senior Research Officer
Uniting Medically Supervised Injecting Centre in Sydney
Australia
Belenko
Steven
Temple University
United States
Bellaert
Lore
Ghent University
Belgium
Benedetti
Elisa
National Research Council - Institute of Clinical Physiology
Italy
Bennet
Andrew
Programme Support Consultant
Public health research, training and consultancy
United Kingdom
Berg
Else Kristin Utne
The Bergen Clinic Foundation
Norway
Bergenström
Anne
EMCDDA
Berkowicz
Katarzyna
iMed FF.Ulisboa, Faculty of Pharmacy ULisboa
Portugal
Berndt
Nadine
National Monitoring Centre for Drugs and Drug Addictions Luxembourg
Luxembourg
Berridge
Virginia
London School of Hygiene and Tropical Medicine
United Kingdom
Bersani
Giuseppe
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome
Italy
Beselia
Ada
Addiction Research Center, Alternative Georgia
Georgia
Best
David
Recovery and Desistance research group, Sheffield Hallam University
United Kingdom
Bialas
Tomasz
Chief Sanitary Inspectorate
Poland
Bilberg
Randi
Unit of Clinical Alcohol Research, University of Southern Denmark
Denmark
Billieux
Joel
Addictive and Compulsive Behaviours Lab. Institute for Health and Behaviour, University of Luxembourg
Luxembourg
Bishop
Lauren
Stockholm University
Sweden
Bista
Sarita
Research Assistant, Midwifery
University of Technology Sydney
Australia
Blaauw
Eric
Hanze University of Applied Sciences
Netherlands
Black
Karen
Turning Point Scotland and University of the West of Scotland
United Kingdom
Black
Nicola
Research Fellow
UNSW · National Drug and Alcohol Research Centre
Sydney
Australia
Blankers
Matthijs
Trimbos Institute
Netherlands
Blickman
Tom
Senior Project Officer
Transnational Institute (TNI)
Amsterdam
Netherlands
Blithikioti
Chrysanthi
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
Barcelona
Spain
Blomme
Eva
Ghent University
Belgium
Boffin
Nicole
Sciensano
Belgium
Bonny-Noach
Hagit
Ariel University and Israeli society of Addiction Medicine (ILSAM)
Israel
Borges
Marta
ARSLVT/DICAD
Portugal
Borle
Prem
Charité Berlin University of Medicine
Germany
Bossong
Matthijs
Trimbos Institute, University Medical Center Utrecht
Netherlands
Botsi
Ourania
Pompidou Group, Council of Europe
Bottel
Laura
LWL-University Hospital, Psychosomatic Medicine
Germany
Boumparis
Nikolaos
VU Amsterdam
Netherlands
Bowden-Jones
Owen
Imperial College London
United Kingdom
Bowden-Jones OBE
Henrietta
Director
National Problem Gambling Clinic
United Kingdom
Braddick
Fleur
Bramness
Jorgen G.
Brand
Matthias
General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen
Germany
Brännström
Linda
National Coordinator
Government's ANDT strategy at the Public Health Agency of Sweden, Unit for Coordination and Analysis.
Sweden
Bravo
Joana
Instituto de Investigação e Inovação em Saúde (i3S)
Portugal
Bredkær Sidenius
Kasper
Bretteville-Jensen
Anne Line
Norwegian Institute of Public Health
Norway
Brito
Leonor
Portugal
Brockmöller
Annemarie
Intel Analyst & Programme Manager CSE
Web-IQ
Netherlands
Brose
Leonie
King's College London
United Kingdom
Brotherhood
Angelina
University of Vienna
Vienna
Austria
Brügger
Mara
Switzerland
Bruggmann
Philip
Arud Centre for Addiction Medicine
Switzerland
Bruner
Ann
Medical Director
Mountain Manor Treatment Center
Baltimore, Maryland
United States
Bruno
Raimondo
University of Tasmania
Australia
Büchel
Christian
Germany
Bühringer
Gerhard
TU University Dresden
Germany
Bukowska
Boguslawa
National Bureau for Drug Prevention
Poland
Burduli
Ekaterina
Washington State University
United States
Burke
Donald S.
Distinguished University Professor of Health Science and Policy and Epidemiology
Graduate School of Public Health, University of Pittsburgh
United States
Burkhart
Gregor
EMCDDA
Burris
Scott
Professor of Law and Public Health
Temple University
United States
Busch
Martin
Epidemiologist and researcher
Austrian Focal Point for Drugs and Drug Addiction
Austria
Busse
Anja
UNODC
Austria
Butterworth
Benjamin
Glasgow Caledonian University
United Kingdom
Buttram
Mance
Nova Southeastern University
United States
Caballería
Elsa
Hospital Clínic
Barcelona
Spain
Caetano
Filipa
Hospital de Magalhães Lemos
Portugal
Caldeira
Maria João
LPC-Policia Judiciária
Portugal
Calder
Robert
Research Associate
Institute of Psychiatry, Psychology and Neuroscience, King's College London
United Kingdom
Camilleri
Moses
Sedqa - Agency for the Treatment of Drug and Alcohol Problems
Malta
Campbell
Gabrielle
UNSW
Australia
Campeny
Eugènia
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona
Spain
Camposeragna
Antonella
Department of Epidemiology
Italy
Carapinha
Ludmila
SICAD
Portugal
Cardoso
Gizela
ARS Norte, DICAD, CRI do Porto Ocidental
Portugal
Cardoso
Manuel
Deputy General Director
SICAD
Portugal
Cardoso
Susana
CRI ORIENTAL
Portugal
Cardoso Seixas
Rita
Luxembourgish National Focal Point, Ministry of Health
Luxembourg
Carew
Anne Marie
Trinity College Dublin
Ireland
Carrola
Joana
FF.Ulisboa
Portugal
Carvalho
Felix
UCIBIO, REQUIMTE, Faculty of Pharmacy, University of Porto
Portugal
Castro André
Rosa
DICAD
Portugal
Castro Calvo
Jesús
Spain
Caudevilla
Fernando
Energy Control Spain
Spain
Caulkins
Jonathan
Carnegie Mellon University
United States
Cetin Seker
Burcu
Turkish Green Crescent Society
Turkey
Chalabianloo
Fatemeh
Haukeland University Hospital, Department of Addiction Medicine
Norway
Chang
Judy
International Network of People Who Use Drugs
Italy
Chung
Sophie
Clark
Luke
University of British Columbia
Canada
Clausen
Thomas
Head of Research Centre
University of Oslo
Norway
Clerckx
Julien
Wide - The Strategic Societal Institute
Belgium
Cockburn
William
European Agency for Safety and Health at Work
Spain
Coelhoso
Filipa
ISCE
Portugal
Coimbra Morais
Rui Miguel
CASO-Portugal
Portugal
Collard
Laurène
Senior Project Manager
Fédération Addiction
Paris
France
Comiskey
Catherine
Trinity College, Dublin University
Dublin
Ireland
Conway
Brian
Vancouver Infectious Dieseases Centre
Canada
Cooper
Leonie
School of Psychology, University of Plymouth
United Kingdom
Corazza
Ornella
University of Hertfordshire
United Kingdom
Costa
Inês
Crescer
Portugal
Costa
Rui
ISPA - Instituto Universitário, Lisbon
Portugal
Costa
Sandra
DICAD-Centro de Respostas Integradas Porto Central Equipa de Tratamento Vila Nova de Gaia- ARS Norte
Portugal
Costa
Vanessa
Center of Neuroscience and Cell Biology, University of Coimbra
Portugal
Costa Storti
Claudia
EMCDDA
Costes
Jean-Michel
ODJ
France
Cote
Melissa
Université du Québec à Trois-Rivières
Canada
Coteur
Kristien
KU Leuven
Belgium
Cousijn
Janna
Universiteit van Amsterdam
Netherlands
Coutinho
Cátia
ARS Norte/DICAD
Portugal
Coutinho
Manuela
ARSN/DICAD/CRI
Viana do Castelo
Portugal
Craft
Sam
King's College London
United Kingdom
Crano
William
Claremont Graduate University
United States
Cunha
Carolina
Faculdade de Psicologia e Ciências da Educação da Universidade do Porto
Portugal
Cunnha Filho
Hilson
Interdisciplinary Centre of Social SciencesFaculty of Social Sciences and Humanities, NOVA University of Lisbon
Portugal
Cunningham
Andrew
EMCDDA
Curado
Adriana
Grupo de Ativistas em Tratamentos (GAT)
Portugal
Czycholl
Dietmar
Supervisor Head / Senior Psychologist
FTK – Fortbildung transkulturell
Germany
D'Arrigo
Laura
Diplomatic advisor
Interministerial Mission for combating drugs and addictive behaviours
Paris
France
Dale
Karen
Dale-Perera
Annette
Director
adpconsultancyUK
United Kingdom
Dali
Gezelle
The University of Melbourne
Australia
Dart
Richard
Director
Rocky Mountain Poison & Drug Center
United States
Das
Pam
Senior Executive Editor
The Lancet
United Kingdom
Dawe
Sharon
Griffith University
Australia
Dawkins
Lynne
Professor of Nicotine and Tobacco Studies
London South Bank University
United Kingdom
De Kock
Charlotte
Ghent University - Institute for Social Drug Research (ISD)
Belgium
De Maeyer
Jessica
Director
Expertise Centre on Quality of Life (E-QUAL), Ghent University College
Belgium
de Sousa Lopes
Rita
ISPA-IU
Portugal
Degenhardt
Louisa
University of New South Wales
Australia
Dehanov
Sara
Hospital Prof. Doutor Fernando Fonseca
Portugal
Demetrovics
Zsolt
Institute of Psychology, ELTE Eötvös Loránd University
Budapest
Hungary
Dias
Helena
ET Stª Maria da Feira
Portugal
Dias
Paula
CRI Porto Oriental
Portugal
Dias
Paulo
Universidade Católica Portuguesa
Portugal
Dias da Silva
Diana
UCIBIO, REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto
Portugal
Diestelkamp
Silke
University Medical Center Hamburg-Eppendorf, German Center for Addiction Research in Childhood and Adolescence
Germany
Dines
Alison
Scientist in Clinical Toxicology
Guy's and St Thomas' NHS Foundation Trust and King’s Health Partners
London
United Kingdom
Diogo
José António
CRI Peninsula Setubal
Portugal
Djukic
Mirjana
University Belgrade-Faculty of Pharmacy
Serbia
Dolu
Osman
Turkey
Dom
Geert
Antwerp University
Belgium
Dores
Artemisa R.
Laboratory of Neuropsychophysiology, Faculty of Psychology and Educational Sciences of University of Porto
Porto
Portugal
dos Santos Reinaldo
Amanda Márcia
Universidade Federal de Minas Gerais
Brazil
Doyle
Anne
Health Research Board
Ireland
Drummond
Colin
King's College London
United Kingdom
Duarte
Noélia
FFUL
Duffell
Erika
European Centre for Disease Prevention and Control
Sweden
Duffin
Tony
Chief Executive Officer
Ana Liffey Drug Project
Dublin
Ireland
Dunlop
Adrian
Hunter New England Local Health District
Australia
Duran
Domingos
SICAD
Portugal
Durand
Louise
RCSI
Ireland
Edegger
Livia
ISSUP
United Kingdom
Edmundson
Claire
Public Health England
United Kingdom
Eide
Desiree
El Mostafi
Hicham
Laboratory of Genetic, Neuroendocrinology and Biotechnology, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco
Morocco
Elgan
Tobias
STAD, Karolinska Institutet
Sweden
Elling
Devy
Department of Public Health Sciences, Stockholm University
Sweden
Elvas Silva
Nuno
Faculty of Pharmacy University of Lisbon
Portugal
Emiliussen
Jakob
University of Southern Denmark
Denmark
Engeli
Etna
Center for Addictive Disorders, Psychiatric Hospital, University Zurich
Switzerland
Engi
Sheila Antonagi
UNIFESP
Brazil
Erikkson Tinghög
Mimmi
Public Health Agency of Sweden
Sweden
Eriksson
Lena
Department of Public Health Sciences
Sweden
Espandian
Ashkan
Clinical Researcher
Unidad de Conductas Adictivas del Complejo Hospitalario de Ourense
Spain
Esteves
Sónia
Art-Therapist
Dependencies an Additives Behaviors Department - ARS - Algarve
Portugal
Estruch
Alexandra
Cookie Box
Barcelona
Spain
Evans-Brown
Michael
EMCDDA
Ezard
Nadine
NCCRED / SVHS / UNSW
Australia
Fadardi
Javad
Professor of the Faculty of Education and Psychology
Ferdowsi University of Mashhad
Iran
Fadeeva
Eugenia
National Medical Research Centre for Psychiatry and Narcology n.a. V.Serbsky Russian Federation Ministry of Health
Russia
Faria
Carolina
Universidade do Porto
Portugal
Faria
Hugo
Ares do Pinhal
Portugal
Farrell
Michael
Director
NDARK, University of New South Wales
Australia
Feingold
Daniel
Ariel University
Israel
Feltmann
Kristin
Karolinska Institut
Sweden
Fernandes
Gwen
Population Health Sciences, Bristol Medical School
United Kingdom
Fernandez Miranda
Juan Jose
AGC SM V-HUCAB-SESPAsturian Mental health service
Spain
Fernandez-Aranda
Fernando
University Hospital of Bellvitge-IDIBELL and CIBERobn
Spain
Ferreira
Daniela Filipa
Faculdade de Psicologia e de Ciências da Educação, Universidade do Porto
Portugal
Ferreira Borges
Carina
Programme Manager, Alcohol and Illicit Drugs Programme & Prisons and Health Programme WHO European Office for Prevention and Control of Noncommunicable Diseases (NCD Office)
Ferri
Marica
Head of sector
EMCDDA
Fincoeur
Bertrand
University of Lausanne
Switzerland
Fineberg
Naomi
Highly Specialized Service for Obsessive Compulsive and Related Disorders, Hertfordshire Partnership University NHS Foundation Trust, University of Hertfordshire
Welwyn Garden City
United Kingdom
Fischer
Benedikt
University of Toronto, Simon Fraser University
Canada
Fischer
Gabriele
Head of the Addiction Clinic
Medical University of Vienna
Austria
Fishman
Marc
Fitzgerald
Niamh
President
International Confederation of ATOD Research Associations, University of Stirling
Stirling
United Kingdom
Flórez
Gerardo
Foley
Michelle
Waterford Institute of Technology
Ireland
Fonseca
Francina
Clinical Researcher
Proceso de Atención a les Adicciones, Hospital del Mar-IMIM
Barcelona
Spain
Fonseca
Joana
FPCEUP
Portugal
Fortin
Davide
Panthéon-Sorbonne University
France
Frango
Paula
SICAD
Portugal
Fraser
Hannah
University of Bristol
United Kingdom
Frederiksen
Kirsten
Centre for Alcohol and Drug Research, Aarhus University
Denmark
Freeman
Tom
Addiction and Mental Health Group
United Kingdom
Freixo
José Carlos
CRI de Braga ARS Norte
Portugal
Frias
Pedro
HML
Portugal
Fridma
Efrat
NYU Silver School of Social Work
United States
Fuertes
Ricardo
Assessor
Câmara Municipal de Lisboa
Portugal
Gabrhelik
Roman
Department of Addictology, 1st Faculty of Medicine, Charles University
Czechia
Gage
Suzanne
University of Liverpool
United Kingdom
Gallegos
Ana
EMCDDA
Galligan
Karen
Trinity College Dublin
Ireland
Gallimberti
Luigi
University Hospital of Padova
Italy
Galvin
Brian
Programme Manager
Drug and Alcohol Research, Health Research Board (HRB)
Ireland
Garretsen
Henk
Tilburg University
Netherlands
Gaspar
Helena
Faculdade de Ciências, Departamento de Química e Bioquímica, Universidade de Lisboa
Portugal
Gaulen
Zhanna
Haukeland University Hospital
Norway
Gegaloto
Américo
SICAD - CDT Setúbal
George
Olivier
Associate Professor and Co-Director
ARC Animal Core Department of Neuroscience, The Scripps Research Institute
United States
Getty
Carol-Ann
King's College London
United Kingdom
Ghita
Alexandra
University of Barcelona
Barcelona
Spain
Gil
Luisa
Centro Hospitalar Psiquiátrico de Lisboa
Lisbon
Portugal
Gilchrist
Gail
King’s College
London
United Kingdom
Gilmore
Sir Ian
Director, Liverpool Centre for Alcohol Research
Chairman, Alcohol Health Alliance
United Kingdom
Gilvarry
Eilish
Honorary Professor of Addiction Psychiatry
Newcastle University
Newcastle
United Kingdom
Giraudon
Isabelle
Principal scientific analyst
EMCDDA
Gisev
Natasa
UNSW Sydney
Australia
Gjersing
Linn
Senior researcher
Norwegian Institute of Public Health
Norway
Godderis
Lode
Goethals
Ilse
University College Ghent
Belgium
Goiana-da-Silva
Francisco
World Health Organization - Regional Office for Europe
Portugal
Gómez
Patricia
University of Santiago de Compostela
Spain
Gomez-Escolar
Anton
Spain
Gonçalves
Filipa
Faculdade de Psicologia e Ciências da Educação da Universidade do Porto
Portugal
Gonçalves
Ricardo
Assistant Professor and Associate Dean for Research
Universidade Católica Portuguesa
Portugal
Goodman
Samantha
University of Waterloo
Canada
Goos
Cees
Public health consultant
Goosdeel
Alexis
Director
EMCDDA
Gorini
Giuseppe
ISPRO
Italy
Gorman
Dennis
Texas A&M University
United States
Goulão
João
Director General
SICAD
Lisbon
Portugal
Grabski
Meryem
University College London
United Kingdom
Grasaasen
Kari
Danish Health Authority
Copenhagen
Denmark
Grebely
Jason
The Kirby Institute, UNSW Sydney
Australia
Gremeaux
Lies
Sciensano
Belgium
Gren
Jakub
Institute of Psychiatry and Neurology
Poland
Griffiths
Mark
Nottingham Trent University
United Kingdom
Griffiths
Paul
Scientific Director
EMCDDA
Gripenberg
Johanna
Research team leader
Center for Psychiatric Research, Karolinska University
Stockholm
Sweden
Groshkova
Teodora
EMCDDA
Portugal
Grzywacz
Anna
Pomeranian Medical University
Poland
Gual
Antoni
Head of the Addictions Unit
Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS
Barcelona
Spain
Guarinieri
Mauro
International Network of People Who Use Drugs
Italy
Guarita
Bruno
EMCDDA
Gust
Steve
NIDA
United States
Hakansson
Anders
Lund University, Department of Clinical Sciences
Lund
Sweden
Hall
Wayne
Professor
Centre for Youth Substance Abuse, Faculty of Health and Behavioural Sciences, University of Queensland
Australia
Halliwell
Gemma
Research Fellow
Handal
Marte
Norwegian Institute of Public Health
Norway
Hansson
Jenny
Analyst
Public Health Agency of Sweden
Sweden
Hare Breidahl
Sibella
King's College London
United Kingdom
Harel-Fisch
Yossi
Bar Ilan University
Israel
Hasselberg
Inês
Scientific writer
EMCDDA
Hauspie
Bert
Ghent University (MICT-IMEC) & University of Applied Sciences Ghent (HoGent)
Belgium
Hedrich
Dagmar
EMCDDA
Heidebrecht
Felicia
London South Bank University
United Kingdom
Heinsbroek
Ellen
Public Health England
United Kingdom
Heitmann
Janika
Henderson
Graeme
University of Bristol
United Kingdom
Henderson
Juliet
Project Manager
Heradstveit
Ove
NORCE Norwegian Research Centre
Norway
Herrera-Sánchez
Isabel María
Vice-Dean of Studies in the Faculty of Psychology
University of Seville
Spain
Herring
Rachel
Middlesex University
United Kingdom
Hesse
Morten
Aarhus University
Denmark
Hester
Rob
University of Melbourne
Australia
Hickman
Matthew
University of Bristol
United Kingdom
Hides
Leanne
CYSAR, University of Queensland
Australia
Higgins
Kathryn
Queens University Belfast
United Kingdom
Hill
Penelope
Burnet Institute
Australia
Hill
Rob
University of Bristol
United Kingdom
Hills
Holly
University of South Florida
United States
Hindocha
Chandni
Hines
Lindsey
Psychiatric epidemiologist
University of Bristol
Hocevar Grom
Ada
NIPH
Slovenia
Holeksa
Julie
Vancouver Infectious Diseases Centre
Canada
Homberg
Judith
Associate Professor
Donders Institute for Brain, Cognition and Behaviour
Netherlands
Homem de Melo
Inês
Hospital Magalhães Lemos and CRI Porto Ocidental
Portugal
Huber
Denis
Executive Secretary
Pompidou Group
Hubert
Pedro
Instituto de Apoio ao Jogador (IAJ)
Lisbon
Portugal
Huestis
Marilyn A.
The Lambert Centre for the Study of Medical Cannabis and Hemps, Institute for Emerging Health Professions, Thomas Jefferson University
Philadelphia
United States
Hughes
Brendan
EMCDDA
Hughes
Caitlin
National Drug and Alcohol Research Centre, UNSW Australia
Australia
Hughes
Karen
Hynes
Márya
CICAD
Washington DC
United States of America
Ioannidis
Konstantinos
Department of Psychiatry, Cambridge University
United Kingdom
Isajeva
Laura
Centre for Disease Prevention and Control of Latvia
Latvia
Ivers
Jo-Hanna
Trinity College Dublin
Ireland
Iwanicki
Janetta
Scientific Director Research and Surveillance
Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority
Denver
United States
Jamt
Ragnhild
Oslo University Hospital
Norway
Jandl
Mateja
National Institute of Public Health
Slovenia
Jandric-Nisevic
Anita
Department of Criminology, Faculty of Education and Rehabilitation Sciences, University of Zagreb
Croatia
Janeiro
Luis
Assistant Professor
Department of Psychology and Educational Sciences, Centre for Research in Psychology (CIP), University of Algarve
Faro
Portugal
Jauffret-Roustide
Marie
Inserm
France
Jauregui
Paula
University of Deusto
Spain
Jérôme
Antoine
Sciensano
Belgium
Jesseman
Rebecca
Director of Policy
Canadian Centre on Substance Use and Addiction
Canada
Jimenez-Murcia
Susana
Head Behavioral Addiction Unit
Bellvitge University Hospital
Barcelona
Spain
Joergenrund
Benedicte
Oslo University Hospital
Norway
Johnson
Amy
Research Assistant
Johnson
Kimberly
Executive Director
International Consortium of Universities for Drug Demand Reduction
United States
Johnson
Mark
United Kingdom
Jones
Christopher
Senior Advisor and Director of Strategy and Innovation
National Center for Injury Prevention and Control, U.S. Centers for Disease Control and Prevention
United States
Jones
Hayley
University of Bristol
United Kingdom
Judge
Deborah
Jurgelaitiene
Lina
Head
National EMCDDA Focal Point of Lithuania
Lithuania
Kabashi
Saranda
Oslo University Hospital
Norway
Kalamara
Eleni
European Asylum Support Office (EASO)
Kalamitsis
George
Hellenic Liver Patients Association 'Prometheus'
Greece
Kamp
Felicia
Department of Psychiatry and Psychotherapy University Hospital Munich, LMU Munich
Germany
Kaner
Eileen
Institute of Health and Society, Newcastle University
United Kingdom
Kang
Kai-Hsiang
National Health Research Institutes
Taiwan
Karaszewska
Hanna
University Adam Mickiewicz
Poznan
Poland
Karjalainen
Karoliina
National Institute for Health and Welfare
Finland
Kashino
Wataru
United Nations Office on Drugs and Crime
Austria
Kavanagh
Elizabeth Clare
Trinity College Dublin
Ireland
Keane
Helen
Australian National University
Australia
Kelly
Jennifer
NHS Greater Glasgow and Clyde Alcohol Drug Recovery Service
United Kingdom
Kelly
Peter
University of Wollongong
Australia
Kilibarda
Biljana
Institute of Public Health of Serbia
Serbia
Kilmer
Beau
Co-Director
RAND Drug Policy Research Center
United States
Kimergård
Andreas
King's College London
United Kingdom
Klein
Axel
Senior Research Fellow
Global Drug Policy Observatory
Swansea
United Kingdom
Klimas
Jan
BCCSU
Canada
Klymanska
Larysa
Lviv Politechnic University
Ukraine
Kools
John-Peter
Trimbos Institute
Netherlands
Korf
Dirk
Bonger Institute of Criminology
The Netherlands
Košir
Matej
UTRIP
Slovenia
Kosorok
Michael R.
Koutsenok
Igor
Professor of Psychiatry
University of California San Diego
United States
Krajewski
Krzysztof
Jagiellonian University
Poland
Kramer Schmidt
Lotte
Motivational Interviewing, fidelity to treatment methods, duration of therapy and other factors that affect outcome of treatment.
Krek
Milan
National Institut of Public Health of Slovenia, National focal point for drugs in REITOX network
Slovenia
Kritikos
Alexandra
Brandeis University
United States
Kun
Bernadette
Institute of Psychology, ELTE Eötvös Loránd University
Budapest
Hungary
Kurcevic
Eliza
Eurasian Harm Reduction Association
Kushakov
Slava
Founding member & senior adviser
Public Health Alliance
Ukraine
Kvillemo
Pia
KI
Sweden
Lam
Tina
Monash University
Australia
Lambert
John
Mater Misericordiae University Hospital
Ireland
Lambrechts
Marie-Claire
KU Leuven, university of Leuven
Belgium
Lampela
Lotta
EU Delegation in Vienna
Austria
Lancaster
Kari
University of New South Wales
Australia
Laniel
Laurent
EMCDDA
Lanz
Janine
Switzerland
Larney
Sarah
University of New South Wales
Australia
Lauvsnes
Anders
NTNU / NKS Kvamsgrindkollektivet
Norway
Laventure
Myriam
Université de Sherbrooke
Canada
Lázaro
Mariana
Centro Hospitalar Psiquiátrico de Lisboa
Portugal
Lees
Rachel
UCL
United Kingdom
Lefrançois
Elodie
School of criminal justice
Switzerland
Leino
Tony
University of Bergen
Norway
Leite
Ângela
Faculdade de Psicologia e de Ciências da Educação da Universidade do Porto
Porto
Portugal
Lemmens
Paul
Associate professor
University of Maastricht
Netherlands
Lengvenyte
Aiste
Vilnius University
Lithuania
Leos-Toro
Cesar
University of Waterloo
Canada
Lewer
Dan
UCL
United Kingdom
Liebregts
Nienke
Bonger Institute of Criminology, University of Amsterdam
Amsterdam
Netherlands
Liem
Marieke
Leiden University
Netherlands
Lim
Aaron
University of Bristol
United Kingdom
Lin
April Liangyu
Singapore Prison Service
Singapore
Linden
David
School for Mental Health and Neuroscience, Maastricht University
Netherlands
Lintzeris
Nicholas
Liquori
Alessandra
UNICRI
Italy
Lobo
Andrea
IBMC-I3S
Portugal
Lofwall
Michelle
Professor of Behavioral Science and Psychiatry and Bell Alcohol and Addictions Chair
University of Kentucky Center on Drug and Alcohol Research
United States
Lombi
Linda
Lopez
Dominique
Independent consultant
India
Lopez-Acuna
Daniel
Spain
Lopez-Gonzalez
Hibai
Bellvitge Biomedical Research Institute (IDIBELL)
Spain
López-Pelayo
Hugo
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona
Spain
Lorenzetti
Valentina
Australian Catholic University
Australia
Lotzman
Natalie
Luf
Anton
Medical University of Vienna
Vienna
Austria
Luginbühl
Marc
Switzerland
Luján
Miguel A.
University Pompeu Fabra
Spain
Lund
Karl Erik
Senior Researcher
Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health
Oslo
Norway
Lynn
Ena
RSCI and HRB
Ireland
Lyons
Suzi
Health Research Board
Ireland
Mabileau
Florence
Pompidou Group, Council of Europe
Mackie
Clare
King's College London
United Kingdom
MacLeod
Katy
National Training and Development Officer
Scottish Drugs Forum
United Kingdom
Maddalena
Nino
Public Health England
United Kingdom
Madeo
Graziella
Madruga
Clarice
Universidade Federal de Sao Paulo
Brazil
Magalhães
Ana
Instituto de Investigação e Inovação em Saúde
Portugal
Magalhães
Cátia
Instituto Politécnico de Viseu e IREFREA
Portugal
Magel
Tianna
Vancouver Infectious Dieseases Centre
Vancouver
Canada
Magen
Carine
Coordinator of the EUROSIDER project
INSERM
France
Mahedy
Liam
University of Bristol
United Kingdom
Mahmood
Zaved
Human Rights and Drug Policy Advisor
Office of the High Commissioner for Human Rights
Maier
Larissa
UCSF
United States
Majó
Xavier
Public health Agency of Catalonia
Spain
Maldonado
Rafael
Pompeu i Fabra University
Barcelona
Spain
Malinowska-Sempruch
Kasia
Open Society Foundations
United States
Malliori
Meni
Greece
Mallorquí-Bagué
Núria
Hospital de la Santa Creu i Sant Pau / Hospital Universitari Bellvitge
Spain
Mancino
Samantha
Universidad Pompeu Fabra
Barcelona
Spain
Mann
Karl
Professor in Psychiatry
Germany
Manthey
Jakob
Technische Universität Dresden
Germany
Maphisa Maphisa
Jabulanis
University of Botswana
Botswana
Marchand
Kirsten
University of British Columbia
Canada
Marel
Christina
Marmet
Simon
Lausanne University Hospital
Switzerland
Marsden
John
King's College London
United Kingdom
Martens
Marcus-Sebastian
University of Hamburg
Germany
Martinell
Thomas
IVO Research Institute
Netherlands
Martinez
Magali
OFDT
France
Martins
Daniel
University of Porto; Kosmicare
Portugal
Martins
Marisa
Hospital Distrital de Santarém
Portugal
Masalin
Teemu
University of Helsinki
Finland
Matheï
Catharina
KU Leuven
Belgium
Mathis
Federica
EMCDDA
Matias
Ana
LPC-PJ
Portugal
Matias
João
Scientific analyst, Public Health unit
EMCDDA
Matilde
Helena
Portugal
Matrai
Silvia
McAuley
Andrew
Glasgow Caledonian University
Glasgow
United Kingdom
McCarthy
Simone
Deakin University
Australia
McCoy
Jacqui
UTAS
Australia
McCracken
John
Director of Commissioning
GambleAware
London
United Kingdom
McHugh
Tina
Mater Misericordiae University Hospital
McNeill
Ann
King's College London
United Kingdom
McPherson
Sterling
Washington State University
United States
Megranahan
Karen
Goldsmiths College
London
United Kingdom
Mejldal
Anna
Mellen
Lisa
Co-Director
Youthinc
United Kingdom
Mellor
Richard
University of New South Wales
Australia
Mendão
Luís
GAT (Grupo de Activistas em Tratamentos)
Portugal
Mendes
Fernando
IREFREA
Portugal
Menel Lemos
Cinthia
Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
Luxembourg
Mercadillo
Roberto
Universidad Autónoma Metropolitana
Mexico
Merendeiro
Cristiana
Crescer
Portugal
Meroueh
Fadi
Pôle Urgences/ CHU de Montpellier Maison d’Arrêt Villeneuve lès Maguelone
France
Metelo
Telma
Portugal
Metrebian
Nicola
Senior Research Fellow in Addictions
King's College London
United Kingdom
Meulewaeter
Florien
Ghent University
Belgium
Meyer
Florian
Division Head in the Department of Social Affairs
City of Zurich
Switzerland
Micallef
Mark
Global Initiative on transitional crime
Michel
Laurent
Centre Pierre Nicole
France
Michels
Ingo
Frankfurt University of Apllied Sciences
Germany
Mikkelsen Ellingsen
Maren
Oslo University Hospital
Norway
Milani
Raffaella Margherita
University of West London
United Kingdom
Milhet
Maitena
OFDT
France
Miquel
Laia
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Barcelona
Spain
Molinaro
Sabrina
National Research Council
Italy
Montanari
Linda
EMCDDA
Monteiro
Anabela
Portugal
Monteiro da Silva
Fábio
Hospital de Magalhães Lemos
Portugal
Moore
Simon
Professor of Public Health Research
United Kingdom
Moreau
Axelle
Université Laval
Canada
Morelli
Angela
CEO / Co-Founder
InfoDesignLab
Oslo
Norway
Morley
Kate
King's College London
United Kingdom
Morris
James
London South Bank University
United Kingdom
Moslah
Bilel
Center Mahmoud Yaacoub for Urgent Medical Assistance
Mota
Daniela
Center for Research, Intervention and Evaluation for Alcohol & Drugs (CREPEIA)
Brazil
Mounteney
Jane
Head of Public Health unit
EMCDDA
Mravčík
Viktor
Office of the Government and associate professor at the Department of Addictology, First Faculty of Medicine, Charles University
Czechia
Muga
Roberto
Hospital Universitari Germans Trias i Pujol
Spain
Müller
Astrid
Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School
Hannover
Germany
Munro
Alison
University of Dundee
United Kingdom
Murray
Sir Robin
Professor of Psychiatric Research
Institute of Psychiatry, Psychology and Neuroscience, King's College London
United Kingdom
Mutatayi
Carine
French Monitoring Centre on Drugs and Drug addiction
France
Nagelhout
Gera
IVO Research Institute and Maastricht University
Netherlands
Nathan
Sally
UNSW Sydney
Australia
Nava
Felice Alfonso
FeDerSerD
Italy
Nave
Américo
CRESCER
Portugal
Nazarova
Anna
Foreign Ministry
Russia
Neale
Joanne
Nechanská
Blanka
Department of Addictology, First Faculty of Medicine, Charles University in Prague
Czechia
Néfau
Thomas
EMCDDA
Negri
Attilio
University of Milan
Italy
Neicun
Jessica
University of Maastricht
Netherlands
Neto Teixeira Bento
Bruno Ricardo
IAJ
Portugal
Neumann
Stefanie
LMU Munich
Germany
Nicholls
James
CEO
Transform Drug Policy Foundation
United Kingdom
Nielsen
Suzanne
Monash University
Australia
Niemelä
Solja
Department of Psychiatry, University of Turku
Finland
Nikkinen
Janne
CEACG, University of Helsinki
Finland
Nogueira
Augusto
CEO
ARTM
Macau
Noor
André
EMCDDA
Nordt
Carlos
University Hospital of Psychiatry Zurich
Switzerland
Notley
Caitlin
University of East Anglia
United Kingdom
Nougier
Marie
Head of Research and Communications
International Drug Policy Consortium
London
United Kingdom
Nunes
Edward
Professor of Psychiatry
Columbia University Medical Center
United States
Nunes
Sofia
Prevention Team of Responses Integrated Center of Ribatejo from DICAD ARSLVT
Portugal
Nunes da Silva
Ana Catarina
Faculdade de Psicologia da Universidade de Lisboa
Portugal
Obradovic
Ivana
Deputy Director
French observatory for drug and drug addiction (OFDT)
France
Ochterbeck
Doris
Leibniz Institute for Prevention Research and Epidemiology - BIPS
Germany
Oksanen
Atte
Tampere University
Finland
Okulicz-Kozaryn
Katarzyna
State Agency for Prevention of Alcohol Related Problems
Poland
Oliveira
Catarina
Hospital Prof. Dr. Fernando Fonseca
Portugal
Oliveira
Maria João
APDES
Portugal
Oliveras
Clara
Hospital Clínic de Barcelona
Barcelona
Spain
Olthof
Marleen
Trimbos Institute
Netherlands
Orio
Laura
Associate Professor
Department of Psychobiology, Complutense University of Madrid
Spain
Oros-Gonzalez
Ariel Alain
Instituto Politecnico Nacional
Mexico
Otiashvili
David
Alternative Georgia
Georgia
Otiniano Campos
Fiorella
Pontificia Universidad Católica del Perú
Peru
O’Donnell
Amy
Institute of Health and Society, Newcastle University
Newcastle upon Tyne
United Kingdom
Pacula
Rosalie
Senior Economist and Co-Director
RAND
United States
Paez-Martinez
Nayeli
Escuela Superior de Medicina. Instituto Politecnico Nacional
Mexico
Palczak
Klaudia
EMCDDA
Palis
Heather
UBC1
Canada
Palmateer
Norah
Senior research follow, Epidemiologist
School of Health & Life Sciences, Glasgow Caledonian University
United Kingdom
Pape
Magdalena
Clinic for Psychosomatic Medicine and Psychotherapy, LWL University Hospital of the Ruhr, University of Bochum
Bochum
Germany
Paraskevopoulos
Ilias
KETHEA
Thessaloniki
Greece
Pardal
Mafalda
Institute for Social Drug Research, Ghent University
Belgium
Pastor
Núria
HumanITcare
Barcelona
Spain
Pates
Richard
ISAJE
United Kingdom
Patrão
Ivone
ISPA-IU
Portugal
Pavlovská
Amalie
Department of Addictology, Charles University
Czechia
Pawelek
Katarzyna
Adam Mickiewicz University
Poland
Pazitny
Martin
Head
PsyIT
Slovakia
Peacock
Amy
Senior Research Fellow
National Drug and Alcohol Research Centre
Australia
Pedersen
Mads Uffe
Aarhus University
Denmark
Pereira
Elizabete
Division for Intervention on Addictive Behaviours and Dependencies of Lisbon
Portugal
Pereira
Luísa
ARSLVT - DICAD - CRI de Lisboa Ocidental
Portugal
Pérez Gayo
Roberto
Correlation - Harm Reduction Network
Netherlands
Peshkovskaya
Anastasia
Peters
Roger
Department of Mental Health Law and Policy, USF
United States
Petruzelka
Benjamin
Department of Addictology, First Faculty of Medicine, Charles University in Prague and General Faculty Hospital in Prague
Czechia
Pettersen
Henning
Innlandet Hospital Trust; Inland Norway University of Applied Sciences
Norway
Pfeiffer-Gerschel
Tim
Institut für Therapieforschung
Germany
Pham
Thanh Luan
Hanoi Medical School
Vietnam
Pich
Michele
Rowan University
United States
Piho
Miia
Tukikohta ry
Finland
Pilarinos
Andreas
University of British Columbia
Canada
Pimenta
Filipa
ISPA - Instituto Universitário
Portugal
Pinto
Alexandra
SICAD
Pinto
António
ARS Algarve at Dependencies an Additives Behaviors Department
Portugal
Pinto
Daniela
Escola Superior de Enfermagem de Coimbra
Coimbra
Portugal
Pires
Joana
Pirona
Alessandro
EMCDDA
Pischke
Claudia
Institute of Medical Sociology,Centre for Health and Society,Medical Faculty, University Düsseldorf
Düsseldorf
Germany
Pitt
Hannah
Deakin University
Australia
Plourde
Chantal
Université du Québec à Trois-Rivières
Canada
Plugge
Emma
Public Health England
United Kingdom
Ponte
Isabel
ARS Norte/DICAD
Portugal
Porras
Bruno
University of Barcelona
Barcelona
Spain
Porreca
Alessio
University of Padua
Padua
Italy
Potenza
Marc
Departments of Psychiatry and Neuroscience, Child Study Center, The Connecticut Council on Problem Gambling, The Connecticut Mental Health Center, Yale University School of Medicine
New Haven
United States
Potter
Alexandra
University of Vermont
United States
Prata Duarte
Isabel
ARSLVT - DICAD - CRI de Lisboa Ocidental
Portugal
Price
Jennifer
Principal Cannabis Compliance Consultant
Abundant Universe
Santa Rosa, California
United States
Proebstl
Lisa
Department of Psychiatry and Psychotherapy University Hospital LMU Munich
Germany
Proença
Cristina
DICAD–Divisão de Intervenção nos Comportamentos Aditivos e nas Dependências
Portugal
Protais
Caroline
French Monitoring Center for Drugs and Drug Addiction
Psederska
Elena
Bulgarian Addictions Institute
Bulgaria
Purshouse
Robin
University of Sheffield
United Kingdom
Quintana
José Benito
Associate Professor
Institute of Food Analysis and Research, Department of Analytical Chemistry
Spain
Rajewska de Mezer
Joanna
Faculty of Educational Studies Adam Mickiewicz University Poznan
Poland
Ramos
João Pedro
Centre for Deviant Behaviour Sciences of FPCEUP
Portugal
Ranson
Florence
Founder
REDComms
Brussels
Belgium
Rehm
Jürgen
Executive Director
Institute for Mental Health Policy Research
Reidy
Mary
Waterford Institute of Technology
Ireland
Reiter
Lothar
Head of Criminal Investigation Department
City Police Zurich
Zurich
Switzerland
Renko
Elina
University of Helsinki
Finland
Resce
Giuliano
Italian National Research Council
Italy
Resch
Doris
Secretariat
CND
Reuter
Peter
Rhodes
Tim
University of New South Wales
Australia
Riper
Heleen
University of Amsterdam
Netherlands
Ritter
Alison
NHMRC Senior Research Fellow
University of New South Wales
Australia
Roberts
Emmert
King's College London
United Kingdom
Robertson
Roy
University of Edinburgh
United Kingdom
Robson
Debbie
Senior Post-Doctoral Researcher in Tobacco Addiction
Institute of Psychiatry, Psychology and Neuroscience, King's College London
United Kingdom
Rocha
Carla
ARSNorte - DICAD
Portugal
Rocha Lopes
Lucas
CHVNG/E
Portugal
Roche
Ann
National Centre for Education and Training on Addiction, Flinders University
Australia
Rodrigues
Sonia
CRI Porto Ocidental
Portugal
Rodriguez de Fonseca
Fernando
Rodriguez-Arias
Marta
Chairman of Psychobiology
University of Valencia
Spain
Rognli
Eline
Oslo University Hospital
Norway
Rolle
Christine
Integrative Drogenhilfe
Germany
Rolová
Gabriela
Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague
Czechia
Romero
Silvana
Université catholique de Louvain
Belgium
Rönkä
Sanna
Head of Reitox National Focal Point
Finnish Institute for Health and Welfare (THL)
Finland
Roque Bravo
Rita
REQUIMTE Laboratory of Toxicology, Biological Sciences Department, Faculty of Pharmacy, University of Porto
Portugal
Rosenkranz
Moritz
Centre for Interdisciplinary Addiction Research, University of Hamburg (ZIS)
Germany
Rossi
Carla
Centro Studi Statistici e Sociali
Italy
Roux
Perrine
INSERM
France
Rouxinol
Daniela
Faculdade de Farmácia, Universidade do Porto
Portugal
Rowicka
Magdalena
Institute of Applied Psychology, Maria Grzegorzewska Academy of Special Education
Warsaw
Poland
Roxburgh
Amanda
National Drug and Alcohol Research Centre, UNSW
Australia
Rueda
Samuel
Department of Social Psychology - University of Sevilla
Spain
Ruiz Muñoz
Manuel Jesús
University of Granada
Spain
Rumpf
Hans-Jürgen
University of Lübeck, Department of Psychiatry and Psychotherapy, Center for Integrative Psychiatry, Research Group S:TEP
Lübeck
Germany
Rush
Brian
CAMH
Canada
Rømer Thomsen
Kristine
Associate Professor
Centre for Alcohol and Drug Research, Aarhus University
Denmark
Saenz
Elizabeth
United Nations Office on Drugs and Crime
Austria
Sáiz
Pilar
Professor of Psychiatry
University of Oviedo
Spain
Saki
Rahim
Director General
International Relations Office of the Drug Control Headquarters
Iran
Salah
Ehab
Prisons and HIV Advisor, HIV/AIDS Section
UNODC
Vienna
Austria
Salama
Essi
University of Turku
Finland
Salgueiro-González
Noelia
Institute of Pharmacological Research Mario Negri-IRCCS
Italy
Samion
Salina
Central Narcotics Bureau
Singapore
Samitca
Sanda
Institute of social and preventive medicine, Centre de médecine générale et de santé publique, Lausanne
Switzerland
Samouco
Ana
Unidade Local de Saúde do Norte Alentejano, E.P.E.
Portugal
Sampayo
Cristina
Faculdade de Farmácia da Universidade de Lisboa
Portugal
Samuelsson
Eva
Stockholm University
Sweden
Sánchez
Unai
HumanITcare
Barcelona
Spain
Sancho Navarro
Marta
Hospital de la Santa Creu i Sant Pau
Spain
Santlal
Kiran
HSE-National Drug Treatment Centre
Ireland
Scafato
Emanuele
Schäffer
Dirk
Referent for Drugs and Prison
Deutsche Aids Hilfe
Germany
Schamp
Julie
Hogeschool Gent
Belgium
Schatz
Eberhard
Correlation European Harm Reduction Network
Netherlands
Schaub
Michael
Swiss Research Institute for Public Health and Addiction
Switzerland
Schecke
Henrike
clinical psychologist
LVR-Clinic Essen, Department of Addictive Behaviour and Addiction Medicine, Faculty of Medicine, University of Duisburg Essen
Germany
Scheibein
Florian
Waterford Institute of Technology
Ireland
Schori
Dominique
Infodrog
Switzerland
Schrooten
Jochen
VAD
Belgium
Schulte
Bernd
Centre for Interdisciplinary Addiction Research, Hamburg University
Hamburg
Germany
Schwarz
John
Seabra
Paulo
Higher Nursing School of Lisbon
Portugal
Sedefov
Roumen
Head of unit, Risks to public safety and security
EMCDDA
Sequeira
Rui
Portugal
Seyler
Thomas
EMCDDA
Shapira
Barak
Hebrew University of Jerusalem
Israel
Shapiro
Harry
DrugWise
Shimmon
Ronald
University of Technology Sydney
Australia
Shirley-Beavan
Sam
Harm Reduction International
United Kingdom
Siefried
Krista J.
The National Centre for Clinical Research on Emerging Drugs (NCCRED)
Australia
Sieroslawski
Janusz
Institute of Psychiatry and Neurology
Poland
Sigmon
Stacey
University of Vermont
United States
Silbernagl
Marisa
Medical University of Vienna
Austria
Silecka-Marek
Ewelina
Faculty and Educational Studies
Poland
Silva
João Pedro
UCIBIO-REQUIMTE, Faculty of Pharmacy, University of Porto
Portugal
Simancas
Diego
First Secretary
Mexican Mission to the UN
Mexico
Simonato
Pierluigi
Addiction psychiatrist
Parco dei Tigli Clinic
Italy
Simonavicius
Erikas
King's College London
United Kingdom
Sinclair
Julia
Professor of Addiction Psychiatry
University of Southampton
United Kingdom
Singleton
Nicola
EMCDDA
Sipala
Floriana
Head of the Organised Crime and Drugs Policy Unit
DG HOME and MIGRATION, European Commission
Belgium
Skar
Mariann
Secretary General
European Alcohol Policy Alliance
Brussels
Belgium
Skogen
Jens Christoffer
Norwegian Institute of Public Health/Alcohol & Drug Research Western Norway, Stavanger University Hospital
Norway
Skryabin
Valentin
Moscow Research and Practical Center on Addictions
Russia
Skurtveit
Svetlana
University of Oslo
Norway
Sleiman
Sandrine
Quality assurance and scientific officer; Reitox and external partners unit
EMCDDA
Portugal
Smit-Rigter
Laura
Trimbos Institute
Netherlands
Smith
Crystal
Washington State University
United States
Soar
Kirstie
University of East London
United Kingdom
Sobol-Goldberg
Shira
Israel
Social robot
Nao
Solgård Svendsen
Thomas
Stavanger University Hospital
Norway
Sort
Anna
Indiehealth, PlayBenefit
Souza Cruz
Olga
ISMAI
Portugal
Sperle-Heupel
Ida
Robert Koch Institute
Berlin
Germany
Starren
Annick
EU-OSHA
Bilbao
Spain
Steinegger
Colette
University of Zurich
Switzerland
Stenius
Kerstin
Stockholm University
Sweden
Stevely
Abigail
University of Sheffield
United Kingdom
Stone
Jack
University of Bristol
United Kingdom
Storbjörk
Jessica
Stockholm University
Sweden
Stöver
Heino
Germany
Stradelmann
Sophie
Institute of social and preventive medicine, Centre de médecine générale et de santé publique, Lausanne
Switzerland
Strang
Sir John
Professor and Head of Department
National Addictions Centre, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London
United Kingdom
Stranz
Richard
European platform coordinator
Coalition Plus
Strumila
Robertas
Vilnius University
Lithuania
Stubbe Østergaard
Liv
Research Assistant
Danish Research Centre for Migration, Ethnicity and Health (MESU), Department of Public Health, University of Copenhagen
Denmark
Sultan
Aysel
Goethe University Frankfurt
Germany
Summavielle
Teresa
I3S, University of Porto
Portugal
Surey
Julian
Institute of Global Health, UCL
United Kingdom
Sypsa
Vana
National and Kapodistrian University of Athens
Greece
Szabo
Attila
Institute of Health Promotion and Sport Sciences, ELTE Eötvös Loránd University
Hungary
Søgaard Nielsen
Anette
Associate Professor
Tadeu
André
Institute of Public Health of University of Porto (ISPUP)
Porto
Portugal
Tammi
Tuukka
National Institute for Health and Welfare
Finland
Tarjan
Anna
Hungarian Reitox National Focal Point
Hungary
Tas
Basak
King's College London
United Kingdom
Tavares
Ana Isabel
DICAD - ARS Norte
Portugal
Tavares
Ana Sofia
ESTES
Portugal
Tavitian-Exley
Isabel
Imperial College
London
United Kingdom
Tavoschi
Lara
University of Pisa
Italy
Temple
Liz
University of New England
Australia
Teodorini
Rachel
London South Bank University
United Kingdom
Thomas
Kyla
University of Bristol
United Kingdom
Thylstrup
Birgitte
Centre for Alcohol and Drug Research
Denmark
Tirado-Muñoz
Judit
IMIM Hospital del Mar Medical Research Institute
Torrens Melich
Marta
Director
Procés d’Addiccions de l’Institut de Neuropsiquiatria i Addiccions del Parc de Salut Mar. Associate Professor of Psychiatry, Universitat Autònoma de Barcelona
Spain
Torres
Analia
Torres da Silva
Natacha
Instituto Português do Desporto e Juventude, I.P.
Portugal
Travis-Roberts
Joanna
Executive Director
ISSUP
Trayner
Kirsten
Glasgow Caledonian University (GCU)
United Kingdom
Tremblay
Joel
Université du Quebec à Trois-Rivières
Canada
Trickey
Adam
University of Bristol
United Kingdom
Trigo
Sofia
SICAD
Portugal
Trotzke
Patrick
University of Duisburg-Essen
Germany
Tylleskär
Ida
Nowegian University of Science and Technology
Norway
Ubartiene
Olga
Lithuania
Urbano
Cláudia
Centro Interdisciplinar de Ciências Sociais, Universidade Nova de Lisboa
Portugal
Urbano Pires
Teodomiro Miguel B. F.
ARSLVT, IP/DICAD/ET-Almada
Portugal
Uusitalo
Susanne
University of Turku
Finland
Vale Pires
Cristiana
Associação Kosmicare e CRIA
Portugal
Valverde
Olga
Chairman of Psychobiology
Departament de Ciències Experimentals i de la Salut, University Pompeu Fabra-Barcelon
Spain
van Baelen
Luk
Sciensano
Belgium
van Beek
Ruben
Trimbos Institute
Netherlands
van de Mheen
Dike
Tranzo Scientific Center for Care and Wellbeing, Tilburg University
Netherlands
van den Bos
Arne
Hanze University of Applied Sciences Groningen
Netherlands
van der Gouwe
Daan
Drug Monitoring & Policy Unit, Trimbos Institute
Netherlands
van der Kreeft
Peer
European Society for Prevention Research, Cardiff University
United Kingdom
van Dijck
Anton
University College of Ghent (HoGent)
Belgium
Van Havere
Tina
Hoge School Gent
Belgium
van Laar
Margriet
Head
Unit Drug Monitoring & Policy at Trimbos Institute
Netherlands
van Miltenburg
Charlotte
Trimbos-institute
Netherlands
Vandam
Liesbeth
Head of the Support to Policy Sector
EMCDDA
Vander Laenen
Freya
IRCP - Ghent University
Belgium
Vanderplasschen
Wouter
Ghent University
Belgium
Vaughn
Becky
Director
Global Centre for Credentialing and Certification
Vella
Anna Maria
PFWS
Malta
Verschure
Paul
Verthein
Uwe
Centre for Interdisciplinary Addiction Research, University of Hamburg (ZIS)
Germany
Vicente
Julian
EMCDDA
Vilar
Graça
Director
SICAD
Portugal
Villa
Rocío
Principado de Asturias Health Service
Spain
Vink
Jacqueline
Vital
Clara
Centro Interdisciplinar de Ciências Sociais, Universidade Nova de Lisboa
Portugal
Vital Brito
Duarte
Central Lisbon Public Health Unit / SICAD
Portugal
Vorobjov
Sigrid
National Institution for Health Development
Estonia
Vrolijk
Ruben
Trimbos Institute
Netherlands
Vuolo
Michael
The Ohio State University
United States
Wadsworth
Elle
University of Waterloo
Canada
Wagner
Vincent
Université de Sherbrooke
Canada
Walderhaug
Espen
Oslo University Hospital
Norway
Waldron
Jon
University College London
Walker
Josephine
University of Bristol
United Kingdom
Wallace
Paul
Professor emeritus
University College London
London
United Kingdom
Walsh
Hannah
King's College London
United Kingdom
Walsh
Sharon L.
Director
Center on Drug and Alcohol Research, University of Kentucky
Lexington, Kentucky
United States
Ward
Zoe
University of Bristol
United Kingdom
Weaver
Timothy
Middlesex University
United Kingdom
Weber
Mirjam
Federal Office of Public Health Switzerland
Switzerland
Weigl
Marion
Gesundheit Österreich
Austria
Weis
Simon
SIP züri
Switzerland
Welch
Sarah
United Kingdom
Welle-Strand
Gabrielle
Section of Clinical Addiction Research, Oslo University Hospital
Norway
Wells
John
Werse
Bernd
Goethe-Universität
Germany
West
Robert
Professor of Health Psychology
University College London
London
United Kingdom
Wiers
Reinout
University of Amsterdam
Netherlands
Wiessing
Lucas
EMCDDA
Winstanley
Erin
West Virginia University
United States
Winstock
Adam
Global Drug Survey and UCL
United Kingdom
Witkiewitz
Katie
Professor of Psychology
University of New Mexico
United States
Wojnar
Marcin
Professor of Psychiatry and the Chair of the Department of Psychiatry
Medical University of Warsaw
Warsaw
Poland
Wolfe
Daniel
International Harm Reduction Development, Open Society Foundations
United States
Wood
David
Guy’s and St Thomas’ NHS Foundation Trust; King’s College London
United Kingdom
Wurst
Frieder
Yates
Christopher
Son Espases Hospital Universitari
Palma de Mallorca
Spain
Yiasemi
Ioanna
Head
Cyprus National Monitoring Centre for Drugs and Drug Addiction
Cyprus
Young
Matthew
Canadian Centre on Substance Use and Addiction
Canada
Zachova
Katerina
Department of Addictology, First Faculty of Medicine, Charles University, Prague
Czechia
Zakrzewska
Karolina
Poland
Zeman
Petr
Institute of Criminology and Social Prevention
Czechia
Zhao
Minqi
Ghent University
Belgium
Zimmermann
Ruth
Robert Koch Institute
Berlin
Germany
Zin-Sedek
Marta
The State Agency for Prevention of Alcohol Related Problems (PARPA)
Poland
Zobel
Frank
Deputy Director
Addiction Switzerland
Switzerland
Zurhold
Heike
Universitätsklinikum Hamburg-Eppendorf
Germany
Zwirn
Gregor
G. Z. Research & Consulting KG
Austria